Nationwide registry of patients with acute heart failure in Korea

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Korean Heart Failure Registry III is a multi-center, prospective registry that enrolls hospitalized adult patients diagnosed with acute heart failure across Korea. The registry aims to analyze various factors including the etiology, treatment approaches, and prognosis of acute heart failure. By collecting comprehensive data, the study seeks to develop effective management strategies for this condition. This observational study will provide valuable insights into the treatment and outcomes of heart failure patients in a real-world setting.

Why it matters

Who can join: the full rules

All consecutive hospitalized adult heart failure patients who fulfill one of 1-3 and 4

Inclusion Criteria:

1. Symptoms of heart failure
2. Signs of heart failure
3. Lung congestion in Chest-x-ray
4. Objective finding of structural and/or functional disorder of the heart or elevated natriuretic peptide levels

Exclusion Criteria:

1. Patients younger than 18 years old
2. Patients who do no consent

Where it's running

• Seoul National University Bundang Hospital
  Seongnam, South Korea Recruiting

Study contacts

• Study coordinator: Dong-Ju Choi, MD, PhD
• Email: djchoi@snubh.org
• Phone: 82317877007

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Infusion of furosemide to see if a loading infusion helps remove fluid better in acute heart failure

  This study tests whether giving furosemide as a continuous infusion with a loading dose is better at removing excess fluid than giving it as bolus injections in adults with acute heart failure.

  Recruiting Phase 4 University of Aarhus · Randers · NCT07577596

• Characterizing phenotypes of acute heart failure

  This project will try to see if heart function measures, imaging features (radiomics), and blood biomarkers can predict outcomes for adults hospitalized with acute heart failure, including cardiogenic shock.

  Recruiting Universitätsklinikum Hamburg-Eppendorf · Hamburg · NCT07508891

• Early finerenone treatment for hospitalized adults with acute heart failure and LVEF ≥40%

  This trial will test whether starting finerenone early during hospitalization helps adults with acute heart failure who have a left ventricular ejection fraction of 40% or higher.

  Recruiting at 13 sites Phase 4 Juntendo University · Handa, Aichi-ken and 20 other locations · NCT07397650

• Intensive GDMT optimization for women after heart failure hospitalization

  This study tests whether rapidly increasing and closely monitoring heart failure meds in women after hospitalization can reduce death or readmission within a year.

  Recruiting Phase 4 IRCCS Policlinico S. Donato · San Donato Milanese, MILANO and 11 other locations · NCT07295522

• Using intra‑abdominal pressure and bedside ultrasound to guide decongestive treatment in heart failure

  This trial will test whether using bladder pressure (intra‑abdominal pressure) measurements together with bedside ultrasound to guide IV loop diuretics helps people hospitalized with acute heart failure get rid of excess fluid more effectively than usual care.

  Recruiting Phase 3 Instituto de Investigación Sanitaria Aragón · Zaragoza and 1 other locations · NCT07008365

• Investigating heart issues in COPD patients during hospital stays

  This study is trying to see if sudden worsening of COPD can cause heart problems in hospitalized patients and how it affects their recovery.

  Recruiting Sahlgrenska University Hospital · Gothenburg, Region Västra Götaland · NCT06597331

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.